News & Events

The Importance of Conference Coverage

Along with numerous networking opportunities, the takeaways regarding industry trends, innovations, discoveries, and advancements are the major benefits of attending an oncology conference. But often, due to the grandiosity of such events, it’s difficult to walk away feeling like you’ve experienced everything you had planned.

 

Even if you were able to attend a number of presentations, network with several key stakeholders, and spend time in the exhibit hall, the sheer amount of information available is simply overwhelming. The main goals, of course, are to take away key industry insights and gain a critical understanding of the presented data.

You may be asking, how is it even possible to meet these goals? The nature of an oncology conference is to pack a lot of information into a little amount of time, making it a challenge to fully digest all the content you’ve just been exposed to. And in some cases, the level of access is an issue; what really happens behind closed-door meetings in the discussions between the key opinion leaders (KOLs)?

 

The right medical communications agencies will offer you a way to make the most of an oncology conference—whether you attend or not. You can subscribe to conference coverage reports. These coverage reports compile all the literature and publications presented at a conference, provide key takeaway points from every presentation, and include conference summaries and insights from KOLs and prominent experts in the field. Let’s explore the benefits of oncology conference coverage, what to look for in choosing a coverage report, and how a report is generated.

 

How Does a Conference Coverage Report Benefit You?
We realize that an important priority when it comes to attending conferences is professional networking, but often this goal drowns out the ability to concentrate on the significant innovations in our field, which are typically unveiled during conference events. Access to an oncology conference coverage report allows you to network and have complete overview of the conference content.

 

These coverage reports make it easy for you to share the conference content with your pharmaceutical or biotech company, letting your work colleagues in on the tricks you picked up at the conference. When you attend a conference, expectations are often to report back on what you learned. Good oncology conference coverage is important because it allows you to report back in an extremely thorough manner with an additional layer of critical understanding, which is provided in the expert analysis that comes with the report.

 

What Should You Look for in Oncology Conference Coverage?
Several agencies and companies offer conference coverage, but there are important things to consider when selecting the best report to purchase. First, look for an agency provider of oncology insights for the life sciences industry with deep knowledge of your therapeutic area and notable experience in the healthcare space. This ensures the report highlights the most valuable content specific to your field and area of interest.

 

Conference summaries should be independent and free from commercial bias. The summaries and insights should be generated by KOLs and experts in a special roundtable congress following the conference. Make sure the agency you choose for your next oncology conference coverage is aligned with a panel of appropriate experts to evaluate and analyze the conference data.

 

Finally, look for a report that is generated from nonbiased scientific interchanges and discussions among leading experts in the field. Of course, meeting coverage reports should give an overview of each tumor type and pathway, but make sure it includes updates on the current and future landscape of that specific disease area, and that it provides future direction.

 

How Is the Conference Coverage Report Generated?
Immediately following the conclusion of a conference, a roundtable discussion will commence and last for about 2 to 3 hours. This usually involves 5 to 6 leading experts presenting data on key abstracts from the conference. Reactions, criticisms, and general insight surrounding the data are gathered and recorded. Further analysis of the data, as they apply to the broader landscape of an evolving science, is also discussed and included in the report. This is invaluable as it considers competitors, new technology, and more, in the context of the information presented at the conference.

 

Conference coverage reports are now typically presented with media-rich content that you can access anywhere on a number of platforms. Look for an agency that allows you to view videos, PowerPoint presentations, original literature, and more, and one that has an active forum where you can continue the conversation even after the conference is over.

 

What Is Extended Conference Coverage?
Not every agency provider of an oncology insights for the life sciences industry offers extended features in their conference coverage reports. However, in some cases, these reports include the opportunity to eavesdrop on the roundtable meeting with the experts, which normally takes place behind closed doors. When you have registered for a conference coverage report upfront, you may be granted access to listen in on the discussion between experts. This serves as an additional way to digest all the information presented at a big medical conference.

 

So, while attending the conference is a special opportunity to meet and reconnect with colleagues, the content presented at a conference is not to be lost. Via a conference coverage report, you will have access to all the content along with unbiased, meaningful commentary from KOLs and experts that you can take back home with you, making the most of your conference experience.

Therapeutic Area

Archives

Matthew Gordon

VP, Real-World Evidence
Matthew has more than 25 years of experience in real-world evidence and observational, non-interventional research. He has led studies across the full life cycle—from startup through publication—supporting objectives that range from understanding a disease’s natural history to fulfilling global safety surveillance requirements. Matthew brings deep expertise in orphan disease programs, having overseen more than 25 long-term, global initiatives, as well as in disease and product registries, prospective pharmacoeconomic studies, and systematic literature reviews. Matthew leads the RWE Registries team, responsible for building the business and team. Prior to joining Aptitude Health, he held senior leadership roles at Parexel, Worldwide Clinical Trials, inVentiv Health Clinical, Quintiles Outcome, and ICON Clinical Research. Matthew holds a BA in sociology from Boston University, is a long-standing member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and is a frequent speaker at ISPOR, the Center for Business Intelligence, and related industry conferences.

Gerald Stanvitch, PhD

VP, Scientific Content

Cate Browning, PhD

VP, Global Medical Affairs

Erin Zingales Rau

VP, Account Services

Kelly Kocor

VP, People & Culture
Kelly leads both the human resources and talent acquisition teams, ensuring that Aptitude Health attracts, retains, and develops top personnel to drive our continued success. With over 17 years of experience transforming global HR initiatives, Kelly is an expert in harmonizing HR policies and fostering a culture of engagement and partnership. She is committed to partnering with all areas of the business to ensure full regulatory compliance and delivering value-added services to our organization and its people. Kelly is passionate about developing and implementing HR strategies that help support our employees’ professional and personal growth. She is dedicated to fostering a culture that encourages innovation, collaboration, and inclusivity, helping Aptitude Health continue to be a great place to work.

Bart Zygmond

VP, Finance
Bart brings a wealth of experience to the organization, having worked in the life sciences, pharmaceuticals, manufacturing, and service industries. With his expertise in financial reporting, US GAAP, SOX, cash flow modeling, and financial analysis, he plays a crucial role in the company’s financial management and strategy. Prior to joining Aptitude Health as VP, Finance, Bart held several controller positions: at Q2 Solutions, he oversaw the global finance team and financial operations, ensuring the accurate and timely financial reporting of the company. He also held controller positions at Domtar Inc and Veristat.

Eugene Vissers, MD

Senior VP, Global Scientific Content
Eugene is a seasoned medical doctor with over 20 years of international experience in pharma, consultancy, and agency environments. Eugene leads the US team of dedicated experts responsible for developing high-quality medical content. Prior to joining Aptitude Health, Eugene served as medical director at Ipsen and AstraZeneca. With both his medical degree and an MBA, Eugene brings a unique perspective to his role. His clinical background, combined with his business acumen, allows him to develop innovative strategies that drive results. Under Eugene’s leadership, the medical content team delivers scientific information of the highest quality, providing valuable insights to our clients around the world.

Adrian Barfield

VP, US Business Development

Kelley Hernandez

Executive VP, US Business Development
Kelley has over 18 years of experience in the oncology space. Kelley joined Aptitude Health after working with Cardinal Health, where she was part of the Healthcare and Analytics Division, and finished her tenure there with VitalSource™ (GPO division). As the leader of the strategic business development team for the US, Kelley brings a wealth of expertise to the organization. Her experience in the healthcare industry, combined with her ability to identify and capitalize on new business opportunities, is invaluable in driving the company’s growth and success. Kelley’s dedication to building strong relationships with life science partners is a testament to her commitment to delivering exceptional value to the healthcare industry.

Adam Sinensky, MBA

Chief Technology Officer

Adam has over 20 years of experience in the healthcare industry and an MBA in healthcare management. After 10 years as a strategy consultant to life science companies, Adam has spent the last decade as a product and strategy leader focused on bringing technology products to market across the payor, provider, and life sciences segments. By combining his business acumen and experience working directly with software developers, engineers, and data scientists, Adam has successfully led numerous product launches and enhancements from ideation to development and go-to-market initiatives. His product and change management expertise has led organizational shifts from services to technology at companies such as Change Healthcare and Datavant/Ciox. At Aptitude Health, Adam is responsible for growing our portfolio of product offerings by leveraging real-world data and artificial intelligence with our existing solutions and industry-leading Axess Network of healthcare providers. He also oversees our IT and cybersecurity teams.

Stefanie Daniels

Chief Commercial Officer

Stefanie is a seasoned healthcare executive with over 20 years of experience in oncology. She brings a wealth of knowledge and expertise to the organization. Stefanie joined Aptitude Health after spending over a decade as a senior director at Physicians’ Education Resource, an oncology CME vendor. During her tenure, she led and managed teams responsible for grant development/acquisition, program creation/execution, and faculty management. Stefanie’s deep understanding of the oncology industry and her ability to lead teams through complex projects make her a vital part of the organization’s success. Her dedication to providing high-quality solutions to our life science partners is a testament to her commitment to improving cancer patient care.

Jason Cash

Chief Financial Officer

Jason is an accomplished finance professional with over 20 years of experience in the pharmaceutical services industry. Throughout his career, he has demonstrated a keen ability to navigate high-growth organizations, delivering exceptional results. Before joining Aptitude Health, Jason served as the CFO of Veristat International, a global contract research organization. In this role, he led the financial strategy and played a pivotal role in driving the company’s growth and success. Jason’s wealth of experience and expertise in financial management make him an essential member of the leadership team. His strategic thinking and ability to drive results are highly respected within the industry.

Jez Moulding

Chief Executive Officer
Jez is a seasoned leader with over 20 years of experience in general management and regional president roles. He has a proven track record of success in the healthcare industry, having worked in the US, Japan, Australia, Korea, South Africa, France, and the UK for Sanofi, where he supported the launch of 10 new drugs across various therapeutic areas. As chief commercial officer at UDG Healthcare and EVP at Ashfield, Jez demonstrated his expertise in developing and implementing successful business strategies. He joined Aptitude Health from Pharmaspectra, an IQVIA business, where he served as CEO since 2018. Jez’s extensive experience in the pharmaceutical industry and his leadership skills make him an invaluable asset to the organization.
Aptitude Health
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.